Bionovo's Menerba Phase 2 trial data to be presented at Annual World Congress on Meno

[News]

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced it will be presenting data from the Phase 2 clinical trial of their lead drug candidate for postmenopausal symptoms, Menerba, to the international community at the 13th Annual World Congress on Menopause in Rome, Italy on June 11, 2011.

More... (http://www.news-medical.net/news/20110604/Bionovos-Menerba-Phase-2-trial-data-to-be-presented-at-Annual-World-Congress-on-Menopause.aspx)